GCM
CAH icon

Gladius Capital Management’s Cardinal Health CAH Stock Holding History

Gladius Capital Management’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,013
Closed -$1.11M – 99
2024
Q3 		$1.11M Buy
10,013
+1,873
+23% +$196K 0.13% 69
2024
Q2 		$800K Sell
8,140
-2,185
-21% -$223K 0.1% 86
2024
Q1 		$1.16M Sell
10,325
-378
-4% -$40.8K 0.38% 56
2023
Q4 		$1.08M Buy
10,703
+6,848
+178% +$679K 0.17% 81
2023
Q3 		$335K Buy
3,855
+239
+7% +$21.6K 0.01% 163
2023
Q2 		$342K Buy
3,616
+415
+13% +$35.1K 0.02% 123
2023
Q1 		$242K Buy
3,201
+131
+4% +$9.88K 0.01% 150
2022
Q4 		$236K Buy
3,070
+2,209
+257% +$168K 0.02% 128
2022
Q3 		$58K Sell
861
-5,464
-86% -$346K ﹤0.01% 205
2022
Q2 		$331K Buy
6,325
+1,267
+25% +$72K 0.02% 140
2022
Q1 		$287K Buy
5,058
+651
+15% +$34.9K 0.02% 137
2021
Q4 		$227K Buy
+4,407
New +$216K 0.02% 173

Other funds holding CAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Gladius Capital Management's CAH Position: Q4 2024 in Review

Gladius Capital Management sold out of Cardinal Health (CAH) in Q4 2024, closing a stake of 10,013 shares — an estimated $1.11M sold.

Gladius Capital Management first reported a position in CAH in Q4 2021 and held it in 12 quarters. The position peaked at $1.16M in Q1 2024. 1,097 funds tracked by Wall St. Rank hold CAH as of Q4 2024.

  • Gladius Capital Management reported no remaining Cardinal Health position as of Q4 2024 after selling out during the quarter.
  • Gladius Capital Management sold 10,013 Cardinal Health shares in Q4 2024, an estimated $1.11M.
  • Gladius Capital Management first reported a position in Cardinal Health in Q4 2021 and held it in 12 quarters.
  • Gladius Capital Management's Cardinal Health position peaked at $1.16M in Q1 2024.
  • 1,097 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2024.

Based on Gladius Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.